Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Overall survival defined as the time from patient inclusion to the date of death or date of last follow-up news (censured data)
7 years
No
Florence MD DALENC
Principal Investigator
Institut Claudius Regaud
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
11 SEIN 07
NCT01574170
May 2012
April 2017
Name | Location |
---|